BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lucendo AJ, López-Sánchez P. Targeted Therapies for Eosinophilic Gastrointestinal Disorders. BioDrugs 2020;34:477-93. [PMID: 32472465 DOI: 10.1007/s40259-020-00427-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Uchida AM, Ro G, Qiang L, Peterson KA, Round J, Dougan M, Dougan SK. Human differentiated eosinophils release IL-13 in response to IL-33 stimulation. Front Immunol 2022;13:946643. [DOI: 10.3389/fimmu.2022.946643] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Chen X, Ding X, Ko HM. Non-esophageal eosinophilic gastrointestinal disorders. Human Pathology Reports 2022;29:300655. [DOI: 10.1016/j.hpr.2022.300655] [Reference Citation Analysis]
3 Lucendo AJ. Drug treatment strategies for eosinophilic esophagitis in adults. Expert Opin Pharmacother 2022;:1-14. [PMID: 35379069 DOI: 10.1080/14656566.2022.2060077] [Reference Citation Analysis]
4 Lucendo AJ, Santander C, Savarino E, Guagnozzi D, Pérez-martínez I, Perelló A, Guardiola-arévalo A, Barrio J, Elena Betoré-glaria M, Gutiérrez-junquera C, Ciriza de los Ríos C, Racca F, Fernández-fernández S, Blas-jhon L, Lund Krarup A, de la Riva S, Naves JE, Carrión S, Rodríguez Oballe JA, García-morales N, Tamarit-sebastián S, Navarro P, Arias Á, Laserna-mendieta EJ, Casabona-francés S, Pérez-fernández T, Llerena Castro R, Ghisa M, Manie D, Pellegatta G, Suárez A, Alcedo J, Gil Simón P, Teresa Palomeque M, Asensio T, Granja-navacerrada A, de Mendoza Guena LH, Rodríguez Sánchez A, Masiques Mas L, Dainese R, Feo-ortega S. EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe. Therap Adv Gastroenterol 2022;15:175628482210742. [DOI: 10.1177/17562848221074204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Feo-ortega S, Lucendo AJ. Evidence-based treatments for eosinophilic esophagitis: insights for the clinician. Therap Adv Gastroenterol 2022;15:175628482110686. [DOI: 10.1177/17562848211068665] [Reference Citation Analysis]
6 Hudhud D, Stashek K, George L, Cross RK. An Adalimumab-Induced Mucosal Red Storm in a Patient with Crohn's Disease. Dig Dis Sci 2022. [PMID: 35034239 DOI: 10.1007/s10620-021-07351-1] [Reference Citation Analysis]
7 Prilutskiy AS. FOOD ALLERGY. POSSIBLE WAYS TO INCREASE THE PREVENTION AND TREATMENT EFFICACY. Juvenis scientia 2022;8:15-34. [DOI: 10.32415/jscientia_2022_8_2_15-34] [Reference Citation Analysis]
8 马 昕. A Case of Eosinophilic Gastroenteritis with Ascites as the First Symptom and Literature Review. ACM 2022;12:40-44. [DOI: 10.12677/acm.2022.121007] [Reference Citation Analysis]
9 Forbes A. Immunosuppressants and immune modulators in luminal gastroenterology. Best Pract Res Clin Gastroenterol 2021;54-55:101759. [PMID: 34874843 DOI: 10.1016/j.bpg.2021.101759] [Reference Citation Analysis]
10 Morgenstern NB, Rochman M, Rothenberg ME. Zooming in on T cell clones: Are we heading to personalized treatment of allergy? Sci Immunol 2021;6:eabj1366. [PMID: 34389614 DOI: 10.1126/sciimmunol.abj1366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sarbinowska J, Wiatrak B, Waśko-Czopnik D. Searching for Noninvasive Predictors of the Diagnosis and Monitoring of Eosinophilic Esophagitis-The Importance of Biomarkers of the Inflammatory Reaction Involving Eosinophils. Biomolecules 2021;11:890. [PMID: 34203871 DOI: 10.3390/biom11060890] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Vande Casteele N, Leighton JA, Pasha SF, Cusimano F, Mookhoek A, Hagen CE, Rosty C, Pai RK, Pai RK. Utilizing Deep Learning to Analyze Whole Slide Images of Colonic Biopsies for Associations Between Eosinophil Density and Clinicopathologic Features in Active Ulcerative Colitis. Inflamm Bowel Dis 2021:izab122. [PMID: 34106256 DOI: 10.1093/ibd/izab122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Fiocchi A, Vickery BP, Wood RA. The use of biologics in food allergy. Clin Exp Allergy 2021;51:1006-18. [PMID: 33966304 DOI: 10.1111/cea.13897] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
14 Fiocchi A, Ebisawa M. Editorial: Food allergy: from defense to attack. Curr Opin Allergy Clin Immunol 2021;21:261-2. [PMID: 33899822 DOI: 10.1097/ACI.0000000000000742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ghisa M, Laserra G, Maniero D, Marabotto E, Barberio B, Pelizzaro F, Barbuscio I, Zingone F, Savarino V, Savarino E. Eosinophilic esophagitis: from pathophysiology to management. Minerva Gastroenterol (Torino) 2022;68:40-8. [PMID: 33267562 DOI: 10.23736/S2724-5985.20.02780-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Arias Á, Lucendo AJ. Epidemiology and risk factors for eosinophilic esophagitis: lessons for clinicians. Expert Rev Gastroenterol Hepatol 2020;14:1069-82. [PMID: 32749898 DOI: 10.1080/17474124.2020.1806054] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]